Out­spo­ken drug pric­ing re­searcher Pe­ter Bach takes CMO gig at liq­uid biop­sy start­up

Af­ter spend­ing more than a decade crit­i­ciz­ing the in­dus­try over drug pric­ing, Memo­r­i­al Sloan Ket­ter­ing’s out­spo­ken re­searcher Pe­ter Bach is jump­ing over to the C …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER